BANK OF AMERICA CORP /DE/ - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 33 filers reported holding SPRING BK PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$2,000
-94.7%
662
-93.6%
0.00%
Q2 2019$38,000
+31.0%
10,284
+274.8%
0.00%
Q1 2019$29,000
-63.3%
2,744
-63.6%
0.00%
Q4 2018$79,000
+132.4%
7,547
+168.6%
0.00%
Q3 2018$34,000
+47.8%
2,810
+44.5%
0.00%
Q2 2018$23,000
-23.3%
1,944
+0.7%
0.00%
Q1 2018$30,000
+650.0%
1,931
+451.7%
0.00%
Q3 2016$4,000
+100.0%
350
+75.0%
0.00%
Q2 2016$2,0002000.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
BVF INC/IL 615,384$8,332,0001.29%
RTW INVESTMENTS, LP 250,000$3,385,0000.71%
Monashee Investment Management LLC 100,000$1,354,0000.57%
PARSONS CAPITAL MANAGEMENT INC/RI 275,728$3,733,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 175,000$2,370,0000.40%
TIEDEMANN ADVISORS, LLC 362,049$4,902,0000.36%
Morse Asset Management, Inc 63,700$862,0000.28%
Private Capital Advisors, Inc. 56,250$762,0000.25%
Crestline Management, LP 98,581$1,335,0000.18%
SECTORAL ASSET MANAGEMENT INC 112,500$1,523,0000.17%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders